Evidence map›Paper›PMID 33164744›Full record

ArticleeLife2020

Distinct insulin granule subpopulations implicated in the secretory pathology of diabetes types 1 and 2.

Alex J B Kreutzberger, Volker Kiessling, Catherine A Doyle, Noah Schenk, Clint M Upchurch, Margaret Elmer-Dixon, Amanda E Ward, Julia Preobraschenski, Syed S Hussein, Weronika Tomaka and 10 more

Abstract readComparative Study
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Alex J B Kreutzberger *Center for Membrane and Cell Physiology, University of Virginia, Charlottesville, United States.ORCID 0000-0002-9774-115X
Volker Kiessling *Center for Membrane and Cell Physiology, University of Virginia, Charlottesville, United States.ORCID 0000-0002-9388-5703
Catherine A DoyleDepartment of Pharmacology, University of Virginia, Charlottesville, United States.
Noah SchenkDepartment of Pharmacology, University of Michigan, Ann Arbor, United States.
Clint M UpchurchDepartment of Pharmacology, University of Virginia, Charlottesville, United States.
Margaret Elmer-DixonCenter for Membrane and Cell Physiology, University of Virginia, Charlottesville, United States.
Amanda E WardCenter for Membrane and Cell Physiology, University of Virginia, Charlottesville, United States.
Julia PreobraschenskiDepartment of Neurobiology, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Syed S HusseinDepartment of Microbiology, University of Virginia, Charlottesville, United States.
Weronika TomakaCenter for Membrane and Cell Physiology, University of Virginia, Charlottesville, United States.
Patrick SeelheimCenter for Membrane and Cell Physiology, University of Virginia, Charlottesville, United States.
Iman KattanDepartment of Neurobiology, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Megan HarrisDepartment of Cell Biology, University of Virginia, Charlottesville, United States.
Binyong LiangCenter for Membrane and Cell Physiology, University of Virginia, Charlottesville, United States.
Anne K KenworthyCenter for Membrane and Cell Physiology, University of Virginia, Charlottesville, United States.
Bimal N DesaiCenter for Membrane and Cell Physiology, University of Virginia, Charlottesville, United States.ORCID 0000-0002-3928-5854
Norbert LeitingerDepartment of Pharmacology, University of Virginia, Charlottesville, United States.
Arun AnantharamDepartment of Pharmacology, University of Michigan, Ann Arbor, United States.
J David CastleCenter for Membrane and Cell Physiology, University of Virginia, Charlottesville, United States.ORCID 0000-0002-5177-4749
Lukas K TammCenter for Membrane and Cell Physiology, University of Virginia, Charlottesville, United States.ORCID 0000-0002-1674-4464

Funding

Structural Dynamics of the Exocytotic Fusion Machine in Neurons.P01GM072694 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI TAMM, LUKAS K · 2005 to 2021
$17.4M
TRPM7 at the Crossroads of Tissue Homeostasis and inflammationR01GM108989 · NIGMS · UNIVERSITY OF VIRGINIA · PI DESAI, BIMAL N. · 2016 to 2024
$3.3M
The Impact of Synaptotagmin Isoform Structure and Diversity on Dense Core Granule ExocytosisR01GM111997 · NIGMS · WAYNE STATE UNIVERSITY · PI ANANTHARAM, ARUN · 2015 to 2019
$1.5M
ABCs of Cholesterol Regulation in the Insulin Secretory PathwayR01DK091296 · NIDDK · UNIVERSITY OF VIRGINIA · PI CASTLE, JOHN DAVID · 2012 to 2015
$1.4M
Mechanistic investigations of HIV restriction by SerincsF30HD101348 · NICHD · UNIVERSITY OF VIRGINIA · PI WARD, AMANDA ELIZABETH · 2020 to 2022
$119k
NICHD NIH HHS F30 HD101348NIDDK NIH HHS R01 DK091296NIGMS NIH HHS P01 GM072694NIGMS NIH HHS R01 GM108989NIGMS NIH HHS R01 GM111997NIH HHS P01 GM072694NIH HHS R01 DK091296
6 · The paper itself

Abstract

Insulin secretion from β-cells is reduced at the onset of type-1 and during type-2 diabetes. Although inflammation and metabolic dysfunction of β-cells elicit secretory defects associated with type-1 or type-2 diabetes, accompanying changes to insulin granules have not been established. To address this, we performed detailed functional analyses of insulin granules purified from cells subjected to model treatments that mimic type-1 and type-2 diabetic conditions and discovered striking shifts in calcium affinities and fusion characteristics. We show that this behavior is correlated with two subpopulations of insulin granules whose relative abundance is differentially shifted depending on diabetic model condition. The two types of granules have different release characteristics, distinct lipid and protein compositions, and package different secretory contents alongside insulin. This complexity of β-cell secretory physiology establishes a direct link between granule subpopulation and type of diabetes and leads to a revised model of secretory changes in the diabetogenic process.

Indexed as

ExocytosisAnimalsCalciumCholesterolCytokinesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2HumansInsulinInsulin-Secreting CellsPalmitatesPC12 CellsRatsSecretory PathwaySNARE ProteinsSphingomyelinsCalciumCholesterolCytokinesInsulinPalmitatesSNARE ProteinsSphingomyelinsSynaptotagminscell biologydiabetesexocytosisfusionhumaninsulinsecretionsynaptotagmin

Identifiers

PMID33164744
PMCPMC7738183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.